PRA Health Sciences | Sustainability Performance
Provides clinical research and healthcare data solutions, supporting drug development and patient care initiatives.
1976
Ireland
10,001+ employees
Biotechnology
$1B - 10B in revenue
$1B - 10B in profitability
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#4935
Overallⓘ#35
in Irelandⓘ#111
in BiotechnologyⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Governance
Targets
Controversy level
- PRA Health Sciences (acquired by ICON in 2021 for USD 12 billion), US clinical research organization, has faced multiple US FDA Form 483 observations at clinical trial sites and the historic 2019 USD 5 million SEC settlement over alleged inadequate disclosure of clinical trial site performance affecting institutional shareholders during the acquisition period.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
11+
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.